B. N. Coşkun Et Al. , "Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?," EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.9, no.2, pp.68-74, 2022
Coşkun, B. N. Et Al. 2022. Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?. EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.9, no.2 , 68-74.
Coşkun, B. N., Yagiz, B., Corabay, S. G., Pehlivan, Y., & Dalkılıç, H. E., (2022). Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?. EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.9, no.2, 68-74.
Coşkun, BELKIS Et Al. "Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?," EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.9, no.2, 68-74, 2022
Coşkun, BELKIS N. Et Al. "Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?." EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.9, no.2, pp.68-74, 2022
Coşkun, B. N. Et Al. (2022) . "Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?." EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.9, no.2, pp.68-74.
@article{article, author={BELKIS NİHAN COŞKUN Et Al. }, title={Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?}, journal={EUROPEAN JOURNAL OF RHEUMATOLOGY}, year=2022, pages={68-74} }